These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12968510)

  • 1. CHD and stroke: Scotland's pandemics also need co-ordinated and vigorous primary prevention programmes.
    Mordue A; Dunbar JA; Vartiainen E
    Scott Med J; 2003 Aug; 48(3):69-72. PubMed ID: 12968510
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
    Lynn MM
    Adv Nurse Pract; 2000 Jun; 8(6):36-41; quiz 42-3. PubMed ID: 15658206
    [No Abstract]   [Full Text] [Related]  

  • 3. [The biological bases for prevention].
    Paoletti R; Poli A
    G Ital Cardiol; 1989 Sep; 19(9):763-9; discussion 778-86. PubMed ID: 2612822
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities and strategies for prevention of ischemic heart disease. Risk factors, trials, mass and individual strategies].
    Menotti A
    G Ital Cardiol; 1989 Sep; 19(9):770-7; discussion 778-86. PubMed ID: 2612823
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive glucose control and cardiovascular outcomes.
    Yudkin JS; Richter B
    Lancet; 2009 Aug; 374(9689):522; author reply 524. PubMed ID: 19683634
    [No Abstract]   [Full Text] [Related]  

  • 6. The Multiple Risk Factor Intervention Trial (MRFIT). A return to a landmark trial.
    Gotto AM
    JAMA; 1997 Feb; 277(7):595-7. PubMed ID: 9032169
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of the cooperative program of multifactorial prevention of ischemic heart disease (results of the 3-year study)].
    Domarkene SB; Baubinene AV; Chazova LV; Kalinina AM; Meĭmanaliev TS; Shleĭfer EA; Davydova LI; Nikolenko EIa; Makhmudov BKh; Karimov TM
    Kardiologiia; 1990 Apr; 30(4):95-8. PubMed ID: 2203931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
    BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary prevention of ischemic heart disease].
    Kruglov VA
    Med Sestra; 1987 Jul; 46(7):12-6. PubMed ID: 3657467
    [No Abstract]   [Full Text] [Related]  

  • 10. In people with no evidence of cardiovascular disease, how effective are interventions aimed at controlling risk factors in reducing all-cause and coronary artery disease mortality?
    Ebrahim S; Davey SG
    West J Med; 2000 Sep; 173(3):185-6. PubMed ID: 10986185
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies.
    Gemmell I; Heller RF; Payne K; Edwards R; Roland M; Durrington P
    Qual Saf Health Care; 2006 Oct; 15(5):339-43. PubMed ID: 17074870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.
    Unal B; Critchley JA; Capewell S
    BMJ; 2005 Sep; 331(7517):614. PubMed ID: 16107431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of epidemiological measures to estimate the impact of primary prevention interventions on CHD, stroke and cancer outcomes: experiences from Herefordshire, UK.
    Syed AM; Talbot-Smith A; Gemmell I
    J Epidemiol Glob Health; 2012 Sep; 2(3):111-24. PubMed ID: 23856450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol reduction to prevent CAD. What do the data show?
    Sorrentino MJ
    Postgrad Med; 2000 Dec; 108(7):40-2, 45-6, 49-52. PubMed ID: 11126142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing aspirin use among persons at risk for cardiovascular events in Oklahoma.
    Mallonee S; Daniels CG; Mold JW; Cline TL
    J Okla State Med Assoc; 2010 Jul; 103(7):254-60. PubMed ID: 20821923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal estradiol use and the risk for cardiovascular mortality.
    Mikkola TS; Tuomikoski P; Lyytinen H; Korhonen P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O
    Hum Reprod; 2016 Apr; 31(4):804-9. PubMed ID: 26874358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension].
    Gysan DB
    Z Kardiol; 2002 Oct; 91(10):777-85. PubMed ID: 12395218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors and primary prevention].
    Richard JL
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1559-60. PubMed ID: 8745988
    [No Abstract]   [Full Text] [Related]  

  • 19. Global epidemic of stroke--need for urgent intervention.
    Bhattacharya AK
    J Indian Med Assoc; 2009 Jun; 107(6):343-4. PubMed ID: 19886369
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of the 5-year program of multi-factorial prevention of ischemic heart disease in men].
    Meĭmanaliev TS; Shleĭfer EA; Madaminov IaK; Gil'fanova VSh; Aĭtmurzaeva GT; Finger EM; Ismailova ChS; Koshaliev EK; Iaroslavtseva OS; Podgurskaia LP
    Sov Med; 1990; (12):57-9. PubMed ID: 2151491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.